Photo by nci from unsplash
e15103Background: Inhibition of immune checkpoints such as PD-1, PD-L1, and CTLA-4, has become an important option in unleashing the immune system to fight cancer. However, there is limited informa... Click to show full abstract
e15103Background: Inhibition of immune checkpoints such as PD-1, PD-L1, and CTLA-4, has become an important option in unleashing the immune system to fight cancer. However, there is limited informa...
Keywords:
immune checkpoint;
checkpoint inhibitors;
rates immune;
oncology;
adoption rates;
inhibitors real
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Clinical Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!